| Chloroquine resistance before and after its withdrawal in Kenya L Mwai, E Ochong, A Abdirahman, SM Kiara, S Ward, G Kokwaro, P Sasi, ... Malaria journal 8, 1-10, 2009 | 224 | 2009 |
| Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial Q Bassat, M Mulenga, H Tinto, P Piola, S Borrmann, C Menendez, ... PloS one 4 (11), e7871, 2009 | 194 | 2009 |
| Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a … S Abdulla, I Sagara, S Borrmann, U D'Alessandro, R González, M Hamel, ... The Lancet 372 (9652), 1819-1827, 2008 | 170 | 2008 |
| Declining Responsiveness of Plasmodium falciparum Infections to Artemisinin-Based Combination Treatments on the Kenyan Coast S Borrmann, P Sasi, L Mwai, M Bashraheil, A Abdallah, S Muriithi, ... PloS one 6 (11), e26005, 2011 | 150 | 2011 |
| Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites S Shekalaghe, M Rutaihwa, PF Billingsley, M Chemba, CA Daubenberger, ... The American journal of tropical medicine and hygiene 91 (3), 471, 2014 | 136 | 2014 |
| Long‐term efavirenz autoinduction and its effect on plasma exposure in HIV patients E Ngaimisi, S Mugusi, OM Minzi, P Sasi, KD Riedel, A Suda, N Ueda, ... Clinical Pharmacology & Therapeutics 88 (5), 676-684, 2010 | 131 | 2010 |
| Effect of Rifampicin and CYP2B6 Genotype on Long‐Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis E Ngaimisi, S Mugusi, O Minzi, P Sasi, KD Riedel, A Suda, N Ueda, ... Clinical Pharmacology & Therapeutics 90 (3), 406-413, 2011 | 90 | 2011 |
| Genome-wide screen identifies new candidate genes associated with artemisinin susceptibility in Plasmodium falciparum in Kenya S Borrmann, J Straimer, L Mwai, A Abdi, A Rippert, J Okombo, S Muriithi, ... Scientific reports 3 (1), 3318, 2013 | 80 | 2013 |
| Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural Kenya A Olotu, G Fegan, TN Williams, P Sasi, E Ogada, E Bauni, J Wambua, ... PLoS One 5 (12), e15569, 2010 | 59 | 2010 |
| Adherence to antiretroviral therapy among HIV infected children measured by caretaker report, medication return, and drug level in Dar Es Salaam, Tanzania FW Mghamba, OMS Minzi, A Massawe, P Sasi BMC pediatrics 13, 1-7, 2013 | 41 | 2013 |
| Metabolic acidosis and other determinants of hemoglobin-oxygen dissociation in severe childhood Plasmodium falciparum malaria P Sasi, SP Burns, C Waruiru, M English, CL Hobson, CG King, M Mosobo, ... American Journal of Tropical Medicine and Hygiene 77 (2), 256-260, 2007 | 38 | 2007 |
| Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy BA Maganda, OMS Minzi, AAR Kamuhabwa, B Ngasala, PG Sasi Malaria journal 13, 1-10, 2014 | 34 | 2014 |
| Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order … SE Cox, EA Ellins, AI Marealle, CR Newton, D Soka, P Sasi, GL Di Tanna, ... The Lancet Haematology 5 (4), e147-e160, 2018 | 32 | 2018 |
| In Vivo and In Vitro Efficacy of Amodiaquine against Plasmodium falciparum in an Area of Continued Use of 4-Aminoquinolines in East Africa P Sasi, A Abdulrahaman, L Mwai, S Muriithi, J Straimer, E Schieck, ... The Journal of infectious diseases 199 (11), 1575-1582, 2009 | 28 | 2009 |
| Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment E Ngaimisi, O Minzi, S Mugusi, P Sasi, KD Riedel, A Suda, N Ueda, ... Journal of Antimicrobial Chemotherapy 69 (12), 3311-3319, 2014 | 25 | 2014 |
| Characterisation of metabolic acidosis in Kenyan children admitted to hospital for acute non-surgical conditions P Sasi, M English, J Berkley, B Lowe, M Shebe, R Mwakesi, G Kokwaro Transactions of the Royal Society of Tropical Medicine and Hygiene 100 (5 …, 2006 | 25 | 2006 |
| Population pharmacokinetics of the antimalarial amodiaquine: a pooled analysis to optimize dosing AM Ali, MA Penny, TA Smith, L Workman, P Sasi, GO Adjei, F Aweeka, ... Antimicrobial agents and chemotherapy 62 (10), 10.1128/aac. 02193-17, 2018 | 24 | 2018 |
| Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania SF Mugusi, E Ngaimisi, MY Janabi, FM Mugusi, OMS Minzi, PG Sasi, ... Antiviral therapy 17 (2), 265-274, 2012 | 24 | 2012 |
| Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator’s product OMS Minzi, IA Marealle, S Shekalaghe, O Juma, E Ngaimisi, M Chemba, ... Malaria journal 12, 1-8, 2013 | 23 | 2013 |
| Adherence to artemether-lumefantrine drug combination: a rural community experience six years after change of malaria treatment policy in Tanzania O Minzi, S Maige, P Sasi, B Ngasala Malaria journal 13, 1-10, 2014 | 21 | 2014 |
